Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic ...

The Centers for Medicare and Medicaid Services plans to terminate four demonstration projects by the end of 2025, closing out ...

It's marketed as a generic option to name-brand mood meds, but it's been recalled for the same reason a competitor was just ...

If drug tariffs don’t work, they could result in higher prices for American patients and increase drug shortages. Testing ...

A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, ...

A study found Indian generics sold in the US between 2009-2018 linked to a 54% higher risk of serious side effects compared ...

Four companies have applied to Health Canada to sell copies of Ozempic after its market exclusivity expires on Jan. 4, 2026 ...

Hint: It's all in the suffix. Viagra, Prozac, Xanax, and Zoloft all went through a process to select memorable names.

A study linking Indian-made generic drugs to a higher risk of serious side effects in the US has drawn backlash from the industry’s most influential lobby group, as India moves to defend its dominant ...

Bill would rein in “pharmacy benefit managers,” or PBMs, which have come under fire for driving up prescription drug costs ...

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Geoffrey Joyce, PhD, director of ...

The Indian Pharmaceutical Alliance refutes a study claiming Indian generic drugs have higher adverse events, stating quality ...